Institute for Translational Oncology Research IRB — Greenville, North Carolina

Institute for Translational Oncology Research IRB is a clinical research site located in Greenville, North Carolina, United States 29605.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Institute for Translational Oncology Research IRB has participated in 1 clinical trials.

Therapeutic areas: Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myelogenous Leukemia (AML).

Sponsors: Celgene.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Institute for Translational Oncology Research IRB?

Institute for Translational Oncology Research IRB has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Institute for Translational Oncology Research IRB conducted?

Institute for Translational Oncology Research IRB has 1 clinical trials on record. Their work covers Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myelogenous Leukemia (AML).

Is Institute for Translational Oncology Research IRB accredited by Crixeo Health?

Institute for Translational Oncology Research IRB has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Institute for Translational Oncology Research IRB?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.